167 related articles for article (PubMed ID: 12972815)
1. Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Gandhi MM; Nathan PC; Weitzman S; Levitt GA
J Pediatr Hematol Oncol; 2003 Sep; 25(9):750-4. PubMed ID: 12972815
[TBL] [Abstract][Full Text] [Related]
2. Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options.
Weaver MS; Navid F; Huppmann A; Meany H; Angiolillo A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):237-41. PubMed ID: 25389917
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.
Wu SY; McCavit TL; Cederberg K; Galindo RL; Leavey PJ
J Pediatr Hematol Oncol; 2015 Jul; 37(5):402-5. PubMed ID: 24608078
[TBL] [Abstract][Full Text] [Related]
4. Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.
Proust S; Benchimol G; Fraitag S; Starck J; Giacobbi V; Pierron G; Bodemer C; Orbach D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28576. PubMed ID: 32896962
[No Abstract] [Full Text] [Related]
5. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
[TBL] [Abstract][Full Text] [Related]
6. Brief report: successful therapy of a patient with infantile generalized myofibromatosis.
Day M; Edwards AO; Weinberg A; Leavey PJ
Med Pediatr Oncol; 2002 May; 38(5):371-3. PubMed ID: 11979466
[No Abstract] [Full Text] [Related]
7. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C
Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894
[TBL] [Abstract][Full Text] [Related]
8. Risk-adapted therapy for infantile myofibromatosis in children.
Levine E; Fréneaux P; Schleiermacher G; Brisse H; Pannier S; Teissier N; Mesples B; Orbach D
Pediatr Blood Cancer; 2012 Jul; 59(1):115-20. PubMed ID: 22038698
[TBL] [Abstract][Full Text] [Related]
9. Diverse presentation and tailored treatment of infantile myofibromatosis: A single-center experience.
Manisterski M; Benish M; Levin D; Shiran SI; Sher O; Gortzak Y; Elhasid R
Pediatr Blood Cancer; 2021 Feb; 68(2):e28769. PubMed ID: 33063933
[TBL] [Abstract][Full Text] [Related]
10. Infantile myofibromatosis.
Larralde M; Ferrari B; Martinez JP; Barbieri MAF; Méndez JH; Casas J
An Bras Dermatol; 2017; 92(6):854-857. PubMed ID: 29364448
[TBL] [Abstract][Full Text] [Related]
11. Infantile myofibromatosis: report on a family with autosomal dominant inheritance and variable penetrance.
Kulkarni K; Desai S; Grundy P; Sergi C
J Pediatr Surg; 2012 Dec; 47(12):2312-5. PubMed ID: 23217896
[TBL] [Abstract][Full Text] [Related]
12. A case of congenital multiple myofibromatosis developing in an infant.
Schrodt BJ; Callen JP
Pediatrics; 1999 Jul; 104(1 Pt 1):113-5. PubMed ID: 10390272
[TBL] [Abstract][Full Text] [Related]
13. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate.
Azzam R; Abboud M; Muwakkit S; Khoury N; Saab R
Pediatr Blood Cancer; 2009 Feb; 52(2):308. PubMed ID: 18937326
[No Abstract] [Full Text] [Related]
14. Remission of infantile generalized myofibromatosis after interferon alpha therapy.
Auriti C; Kieran MW; Deb G; Devito R; Pasquini L; Danhaive O
J Pediatr Hematol Oncol; 2008 Feb; 30(2):179-81. PubMed ID: 18376275
[TBL] [Abstract][Full Text] [Related]
15. Congenital-infantile fibrosarcoma of the foot--avoidance of amputation.
Nason GJ; Baker JF; Seoighe D; Irvine AD; McDermott M; Orr D; Capra M; Kelly PM
Ir Med J; 2014 May; 107(5):148-9. PubMed ID: 24908860
[TBL] [Abstract][Full Text] [Related]
16. Special imaging casebook. Infantile myofibromatosis: solitary and multifocal varieties.
Herman TE; Siegel MJ
J Perinatol; 1995; 15(3):250-2. PubMed ID: 7666279
[No Abstract] [Full Text] [Related]
17. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
Stein ME; Lachter J; Spencer D; Bezwoda WR
Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment in infantile choriocarcinoma.
Hongo T; Fujii Y; Fukuoka T; Iijima S; Matsusita T; Nakagawa Y; Igarashi Y
Acta Paediatr Jpn; 1992 Feb; 34(1):52-9. PubMed ID: 1580153
[TBL] [Abstract][Full Text] [Related]
19. Recurrent infantile myofibromatosis: a report of conservative management and discussion of treatment strategies.
Ebert CS; Zdanski C; Ardeshirpour F; Patel M; Hart CF; Drake AF
Ear Nose Throat J; 2008 Dec; 87(12):E4. PubMed ID: 19105133
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)].
Pilz T; Pilgrim TB; Bisogno G; Knietig R; Koscielniak E; Carli M; Treuner J
Klin Padiatr; 1999; 211(4):291-5. PubMed ID: 10472564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
